MYC and small cell lung carcinoma: Notably, Kanemura et al. (Kanemura et al. 2022) also found that  SRY-related high-mobility-group box 11(SOX11) (p < 0.001, false discovery rate (FDR) < 0.001) and myelocytomatosis (MYC) (p = 0.02, FDR = 0.06) were the top two up-regulated genes in non-inflammatory tumors relative to inflamed tumors in the above-mentioned study, which suggested that SOX11 and MYC may contribute to poor immune response in SCLC.